Search

CI music: seeking perfection, accepting reality

Having just read about the challenges cochlear implant technology and music appreciation present, the musician Richard Reed beautifully illustrates the realities of this patient journey. An old friend of mine is an ardent music fan, and completely tone deaf. Long...

BACO: evolution and modernisation

Chairing the local organising committee is no small task, but it has a personal connection for Tim Woolford, as he tells us. I attended my first BACO in Manchester as a registrar, and have attended every one since. In July,...

OBITUARY: David Moffat (1948-2020)

David Moffat, one of the leading Otologists of his generation, died on 18 March in Addenbrooke’s Hospital in Cambridge, the hospital to which he had devoted his professional life. Having survived cancer of the prostate, he succumbed to a second...

Benchmarking for innovation in healthcare ­– an approach from 
Down Under and a gap in the 
National Health Service?

Benchmarking is a process of comparison between the performance characteristics of separate, often competing, organisations intended to enable each participant to improve its own performance [1]. Often, in healthcare, benchmarking is carried out by central government departments or regional agencies...

In conversation with Jayne Fletcher-Brander

What is the process to bring music to a Deaf audience and does it enhance the experience of the hearing viewers? In this interview, Deaf SingSong performer, Jayne Fletcher-Brander takes us through the journey of bringing a signed musical performance...

Wisdom and the cochlear implant clinician

Helen Cullington provides the clinician’s perspective on the challenges faced in building artificial intelligence into cochlear implant clinics. She highlights the importance of including the clinician with their wisdom and experience to help make sense of the patterns of data....

COOL therapy for cisplatin-induced hearing loss

Cisplatin is a commonly used cancer therapy, with nearly 50% of patients undergoing chemotherapy receiving cisplatin as part of their regimen [1]. Depending on the dose, incidence of hearing loss has been reported as 12-100% in adults, and 37-94% in...

Rapid genetic testing to avoid hearing loss in neonates

Thousands of newborn babies could avoid a lifetime of hearing loss thanks to a new rapid genetic test. In this article, we learn how. We have demonstrated for the first time that a rapid genetic test from a cheek swab...

Platinum-based chemotherapy, tinnitus and hearing loss

Fortunately, the five-year survival rate of adult cancers is increasing. However, we are seeing for the first time the lasting effects of cancer treatments on people. As more people live with the long-term effects of treatment, such as chemotherapy, it is imperative to understand the impact it has on quality of life.